MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY
Mangoceuticals, Inc. (MGRX)
Company Research
Source: GlobeNewswire
San Francisco Fans Nationwide Get Three Free Mangorx ED Pills Based on Sunday’s Game Point Difference Dallas, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a men’s health & wellness company, will offer a free one-year supply of its “Mango” erectile dysfunction product to the San Francisco players and coaches to raise spirits following Sunday’s Big Game loss, ensuring they can still perform in the bedroom after losing on the field. MangoRx is committed to helping men tackle hard issues. In addition to offering the losing team players the opportunity to score, fans can also get in on the fun with a special discount code equal to 3 free Mango pills, the game’s point difference. Fans can use the code “SB58”, now available through February 29, 2024. Players and coaches of the SF-based team can send redemption inquiries to hello@mangorx.com with subject line “The Big Game” for access to their one-year supply of Ma
Show less
Read more
Impact Snapshot
Event Time:
MGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGRX alerts
High impacting Mangoceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MGRX
News
- Mangoceuticals acquires a global patent portfolio [Seeking Alpha]Seeking Alpha
- Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareGlobeNewswire
- Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsGlobeNewswire
- MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®? FDA Approved Oral Testosterone Replacement Therapy (TRT) TreatmentGlobeNewswire
- MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue GrowthGlobeNewswire
MGRX
Sec Filings
- 4/25/24 - Form 8-K
- 4/23/24 - Form S-1
- 4/11/24 - Form 8-K
- MGRX's page on the SEC website